C6 NBD Galactosylceramide,cas:170212-26-7
C6 NBD Galactosylceramide
Catalog # | Pkg Size | Price(USD) | Quantity | Buy this product |
---|---|---|---|---|
R-M-5688 | 200ug | 640.00 | + Add to cart |
|
R-M-5688 | 500ug | 1360.00 | + Add to cart |
|
|
Product description
C6 NBD galactosylceramide is a galactosylceramide derivative that is tagged with a fluorescent group C6 nitrobenzoxadiazole (C6 NBD). C6 NBD galactosylceramide has been used to study intracellular localization and metabolism of galactosylceramide, which is a marker of Krabbe disease.
Appearance | N/A |
---|---|
Molecular weight | 737.9 |
Purity | >95% |
Solubility | N/A |
Molecular formula | C36H59N5O11 |
Cas | 170212-26-7 |
Synonyms | N-hexanoyl-NBD-Galactosylceramide; N-[(1S,2R,3E)-1-[(β-D-galactopyranosyloxy)methyl]-2-hydroxy-3-heptadecen-1-yl]-6-[(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]-hexanamide |
Storage | -20℃, protected from light and moisture |
Transportation | 4-25℃ temperature for up to 2 weeks |
Stability | 1 year |
Document
Related Product